EUVIMEDEUVIMED entdecken
Crossref

L26/P-221 Effect of calcium ionophore on fertilization and embryo quality: a randomized sibling-oocyte controlled trial

C.H. Kung, K.C. Lan

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C.H. Kung und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does treatment with calcium ionophore improve the normal fertilization rate (2PN) in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) cycles? Summary answer Calcium ionophore did not improve overall 2PN fertilization or embryo quality and was associated with reduced blastocyst scores, despite higher fertilization in ICSI cycles. What is known already Artificial oocyte activation using calcium ionophores has been proposed to overcome fertilization failure following IVF/ICSI, but evidence regarding its effect on embryo development and clinical outcomes remains inconsistent. Study design, size, duration This was a prospective randomized sibling-oocyte controlled trial conducted between January 2023 and March 2025, including 720 oocytes from 63 patients across 84 IVF/ICSI cycles. Mature oocytes within each cycle were randomly allocated to calcium ionophore (GM508 CultActive; Gynemed, Germany) treatment or untreated control groups, allowing within-patient comparison. Embryo grading was performed by two senior embryologists following routine practice. Participants/materials, setting, methods After IVF or ICSI, oocytes were allocated to calcium ionophore (GM508) or no additional treatment. Embryos were cultured in a time-lapse imaging system and evaluated on Days 1, 2, 3, and 5 using standardized morphological grading systems. The primary outcome was normal fertilization (2PN). Secondary outcomes included blastocyst formation, blastocyst score, and clinical pregnancy with followed up until May 2025. Paired statistical analyses and generalized estimating equations were applied to account for within-patient correlations. Main results and the role of chance Among 720 oocytes, the overall normal fertilization rate (2PN) did not differ significantly between the calcium ionophore and control groups (75% ± 2% vs. 71% ± 3%, p = 0.242). Day 5 and overall blastocyst morphological scores were significantly lower in the calcium ionophore group (Day 5: 2.4 ± 0.2 vs. 3.1 ± 0.2; overall: 2.5 ± 0.2 vs. 3.2 ± 0.2; both p = 0.011). In subgroup analysis, calcium ionophore significantly increased normal fertilization rate in ICSI cycles (89% ± 5% vs. 74% ± 6%, p = 0.047), but was associated with reduced blastocyst morphological scores (2.1 ± 0.4 vs. 3.6 ± 0.4, p = 0.015). Clinical pregnancy rates were comparable between groups (33.3% vs. 36.7%, p > 0.05). Limitations, reasons for caution The study was conducted at a single center with a relatively limited sample size for clinical outcomes. Live birth and neonatal outcomes were not assessed. Wider implications of the findings These findings suggest that routine use of calcium ionophore does not improve embryo quality or pregnancy outcomes and may adversely affect blastocyst morphology. Its use may therefore be considered only in carefully selected ICSI cases with previous fertilization failure, rather than as part of routine IVF practice. Trial registration number Yes

Zitieren

APA

Kung, C., & Lan, K. (2026). L26/P-221 Effect of calcium ionophore on fertilization and embryo quality: a randomized sibling-oocyte controlled trial. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.557

Vancouver

Kung C, Lan K. L26/P-221 Effect of calcium ionophore on fertilization and embryo quality: a randomized sibling-oocyte controlled trial. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.557

BibTeX
@article{Kung2026,
  author = {Kung, C.H. and Lan, K.C.},
  title = {L26/P-221 Effect of calcium ionophore on fertilization and embryo quality: a randomized sibling-oocyte controlled trial},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.557}
}
Kostenlos starten →